AECOS 2020 Summer Webinar Series
June 25-August 1, 2020

The American-European Congress of Ophthalmic Surgery will be hosting the 2020 AECOS Summer Webinar Program this year through a series of 2 hour live interactive sessions starting June 25th. Key opinion leading surgeons, Steven Dell, MD, Bill Trattler, MD, Francesco Carones, MD, Sheraz Daya, MD, Erik Mertens, MD and William Link, MD will facilitate these sessions to discuss hot topics and innovation among ophthalmic industry leaders. Centricity Vision – ZEPTO® Precision Cataract Surgery looks forward to sponsoring this event that is open to all AECOS members as well as non-members with no fee to participate.

2020 Ophthalmology Futures Forums
September 30-October 1, 2020

Keith Barton and Kuldev Singh announce a virtual format for this year’s Ophthalmology Retina and European Futures Forums, to facilitate maximum participation across all forums.

2020 ESCRS Annual Congress
October 2-4, 2020
2020 AAO Annual Meeting
Las Vegas, NV USA
November 14-16, 2020



Mynosys Changes Name to Centricity Vision and Names New Leadership Team
May 28, 2020
Centricity Vision, Inc., formerly known as Mynosys Cellular Devices, Inc., a global ophthalmic technology company dedicated to delivering products that help surgeons optimize outcomes in refractive surgery, today announced a new executive leadership team, along with a new company name.
How to Center Capsulotomy in Cataract Surgery (Healio)
April 21, 2020
At Hawaiian Eye 2020 in Koloa, Hawaii; Vance Thompson, MD, discusses the use of ZEPTO® automated capsulotomy in centering cataract surgery on the visual axis using Purkinje images.
EyeWorld Asia Pacific – “Capsulotomy Creation: Searching for Perfection”
March 2, 2020
Rich Daly, EyeWorld Contributing Writer reviews Dr. Uday Devgan’s and Dr. Larry Patterson’s various approaches to capsulotomy creation discussing ZEPTO® as one of the methods. Dr. Chee Soon Phaik, MD (Singapore) provides her approach to capsulotomy highlighting the benefits of ZEPTO®.
Mynosys Cellular Devices, Inc. Secures $25 Million Investment From Decheng Capital; Names Veteran Ophthalmic Executive Rob Thornhill as CEO
November 9, 2019
Mynosys Cellular Devices, Inc., manufacturer of the Zepto® cataract surgery device, today announced it finalized a $25 million financing round, led by Decheng Capital, and named veteran ophthalmology industry executive Rob Thornhill as Chief Executive Officer.
Precision pulse capsulotomy in challenging cataract surgery cases
July 29, 2019
A new case study using the Zepto® Precision Cataract Surgery system was published on July 25, 2019 in Clinical Ophthalmology: "Precision pulse capsulotomy in challenging cataract surgery cases.
Dr. Vance Thompson Interviewed at OSN Italy 2019 (Healio)
May 28, 2019
At the OSN Italy meeting, Dr. Vance Thompson gave the Benedetto Strampelli Medal Lecture. He discussed how to use the Purkinje images for centration, and performing a capsulotomy manually or with various technologies, including using Zepto®.